External Ventricular Drainage Post-Market Clinical Follow-up Registry

Inclusion Criteria

• Patient and/or legally authorized representative has agreed to participate in the study by signing the EC-approved consent form, where applicable.
• Patients (of any age) who underwent or who plan to have a procedure with one of the Integra or Codman External Ventricular Drainage System.
• For patients who have had the EVD System removed prior to study enrollment, have available follow-up data from implant until the EVD System is no longer required for drainage and monitoring of CSF.

Exclusion Criteria

• The Patients in whom more than one EVD System were or are intended to be placed.
• The Patient has sepsis.
• The Patient has a history of poor wound healing.
• The patient exhibits signs of scalp infection prior to implantation that would be contraindicated per the IFU.
• The Patient is otherwise determined by the Investigator to be medically unsuitable for participation in this Registry.
• The Patient is currently enrolled in another device trial or has been previously entered in this trial.
• The Patient is a prisoner or member of a different vulnerable population that should not be included in the study per the investigator.
• The Patients known to have uncorrected coagulopathy.
• The Patients with known hypersensitivity to rifampin or clindamycin hydrochloride (prior to implantation of Bactiseal catheters)